Skip to content

Prognostic validity of blood pressure to vasopressor ratio in shock: a single-center retrospective cohort study

Prognostic validity of mean arterial pressure to norepinephrine equivalent dose ratio for mortality in critically ill patients: a single-center retrospective cohort study - Mean arterial pressure to vasopressor ratio in shock

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000058995
Enrollment
900
Registered
2025-09-04
Start date
2024-07-31
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Shock

Interventions

None listed

Sponsors

Kameda Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: All adult patients (18 years or older), who received a continuous infusion of norepinephrine base of 5 mcg/min or greater within the first 24 hours after ICU admission between November 2, 2020 and June 30, 2024.

Exclusion criteria

Exclusion criteria: We excluded patients who stayed in the ICU for less than 24 hours, patients undergoing mechanical circulatory support (venoarterial extracorporeal membrane oxygenation, intraaortic balloon pumping, microaxial flow pump, ventricular assist device), patients without invasive arterial blood pressure monitoring, and patients who opted out of this study.

Design outcomes

Primary

MeasureTime frame
Hospital mortality

Secondary

MeasureTime frame
Intensive care unit mortality

Countries

Japan

Contacts

Public ContactYuki Kotani

Kameda Medical Center Department of Intensive Care Medicine

dkivoar287@gmail.com0470922211

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026